Curis
CRIS
#11055
Rank
S$5.99 M
Marketcap
S$0.63
Share price
4.24%
Change (1 day)
-57.26%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): S-$18.37

According to Curis's latest financial reports the company's current EPS (TTM) is S-$18.33. In 2025 the company made an earnings per share (EPS) of S-$30.69 an increase over its 2024 EPS that were of S-$181.25.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$18.37-40.15%
2025S-$30.69-83.07%
2024S-$181.25-22.15%
2023S-$232.81-26.17%
2022S-$315.3122.3%
2021S-$257.82-25.37%
2020S-$345.48-30.93%
2019S-$500.17-2.02%
2018S-$510.48
2016S-$1,160-10%
2015S-$1,289138.1%
2014S-$541.4240%
2013S-$386.73-25%
2012S-$515.6466.67%
2011S-$309.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$0.92-104.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.83-131.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.46-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$4.46-124.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$5.61-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$4.10-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S-$6.50-64.56%๐Ÿ‡บ๐Ÿ‡ธ USA